Desferal

aluminum, deferoxamine infusion test, Chronic aluminum overload + 3 more

Treatment

8 FDA approvals

0 Active Studies for Desferal

What is Desferal

Deferoxamine

The Generic name of this drug

Treatment Summary

Desferrioxamine is a natural substance extracted from a type of bacteria called Streptomyces pilosus. It binds to iron in the body, making it useful as a chelating agent, which is a type of medicine used to treat certain conditions. Desferrioxamine is usually taken in the form of a mesylate salt.

Desferal

is the brand name

image of different drug pills on a surface

Desferal Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Desferal

Deferoxamine

1968

19

Approved as Treatment by the FDA

Deferoxamine, also known as Desferal, is approved by the FDA for 8 uses which include Iron Overload and End-stage Renal Failure (ESRF) .

Iron Overload

End-stage Renal Failure (ESRF)

Kidney Failure, Chronic

Chronic aluminum overload

deferoxamine infusion test

Iron Overload

Iron Overload

aluminum

Effectiveness

How Desferal Affects Patients

Deferoxamine, also known as desferrioxamine or desferal, is a drug that helps the body get rid of extra iron or aluminum. It attaches to the extra iron or aluminum in the blood and makes them easier to pass out in urine. This helps reduce damage to organs, such as the liver, caused by the extra iron or aluminum.

How Desferal works in the body

Deferoxamine helps remove toxic levels of iron and aluminum from the body. It has a strong affinity for ferric iron and aluminum, binding them to form stable complexes. 100 mg of deferoxamine can bind 8.5 mg of ferric iron and 4.1 mg of aluminum. These complexes are then eliminated from the body via the kidneys or, in the case of aluminum, through dialysis.

When to interrupt dosage

The proposed measure of Desferal is conditional on the determined condition, including Iron Overload, Chronic aluminum overload and deferoxamine infusion test. The amount of dosage fluctuates, according to the technique of delivery featured in the table beneath.

Condition

Dosage

Administration

aluminum

, 500.0 mg, 2000.0 mg, 95.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL

, Powder, for solution, Powder, for solution - Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous

deferoxamine infusion test

, 500.0 mg, 2000.0 mg, 95.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL

, Powder, for solution, Powder, for solution - Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous

Chronic aluminum overload

, 500.0 mg, 2000.0 mg, 95.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL

, Powder, for solution, Powder, for solution - Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous

Iron Overload

, 500.0 mg, 2000.0 mg, 95.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL

, Powder, for solution, Powder, for solution - Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous

Iron Overload

, 500.0 mg, 2000.0 mg, 95.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL

, Powder, for solution, Powder, for solution - Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous

Kidney Failure, Chronic

, 500.0 mg, 2000.0 mg, 95.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL

, Powder, for solution, Powder, for solution - Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intraperitoneal; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous

Warnings

Desferal Contraindications

Condition

Risk Level

Notes

Anuria

Do Not Combine

Kidney Diseases

Do Not Combine

There are 2 known major drug interactions with Desferal.

Common Desferal Drug Interactions

Drug Name

Risk Level

Description

Prochlorperazine

Major

The risk or severity of adverse effects can be increased when Deferoxamine is combined with Prochlorperazine.

Technetium Tc-99m oxidronate

Major

Deferoxamine may decrease effectiveness of Technetium Tc-99m oxidronate as a diagnostic agent.

Desferal Toxicity & Overdose Risk

In mice, rats, and rabbits the toxic dose through injection is 340 mg/kg, 520 mg/kg, and 600 mg/kg, respectively. The toxic dose through subcutaneous injection in mice and rats is 1600 mg/kg and over 1000 mg/kg, respectively. Through oral administration, the toxic dose in mice and rats is over 3000 mg/kg and over 1000 mg/kg, respectively. Long-term use of this drug can lead to kidney damage, hearing loss, and eye damage.

Desferal Novel Uses: Which Conditions Have a Clinical Trial Featuring Desferal?

Four clinical trials are actively investigating the potential of Desferal to reduce Chronic aluminum accumulation, aluminum and Iron Overload.

Condition

Clinical Trials

Trial Phases

Iron Overload

0 Actively Recruiting

deferoxamine infusion test

0 Actively Recruiting

Iron Overload

0 Actively Recruiting

aluminum

0 Actively Recruiting

Kidney Failure, Chronic

0 Actively Recruiting

Chronic aluminum overload

0 Actively Recruiting

Desferal Reviews: What are patients saying about Desferal?

3

Patient Review

10/18/2011

Desferal for Too Much Iron in the Blood for a Long Period of Time

My blood iron level was really high when I got this treatment, but it's gone down since then.

3

Patient Review

10/18/2011

Desferal for Too Much Iron in the Blood for a Long Period of Time

This medication helped me get my high blood iron level under control.

1

Patient Review

9/4/2012

Desferal for Aluminum Poisoning

This did not help me at all.

1

Patient Review

9/4/2012

Desferal for Aluminum Poisoning

This was not effective for me at all.

Patient Q&A Section about desferal

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Desferal infusion?

"Desferal is a medication used to treat sudden iron poisoning, most effectively when given soon after the iron was consumed. It is used in conjunction with other treatments, such as causing vomiting with syrup of ipecac or stomach pumping."

Answered by AI

What are the side effects of Desferal?

"gas, or upset stomach

injection site reactions can include: pain, swelling, burning, redness, irritation, or a hard lump), blurred vision,, dizziness,, ringing in your ears,, flushing (warmth, redness, or tingly feeling),, itching or skin rash,, numbness or burning pain anywhere in the body,, diarrhea, gas, or upset stomach"

Answered by AI

How do you administer Desferal?

"A daily dose of 500-1000 mg of Desferal should be given intramuscularly. In addition, 2000 mg of Desferal should be given intravenously with each unit of blood transfused; however, Desferal should be given separately from the blood. The rate of intravenous infusion must not exceed 15 mg/kg/hr."

Answered by AI

What is Desferal used for?

"Desferal is an injection that helps remove too much iron or aluminum from your blood. The main active ingredient in Desferal, desferrioxamine mesilate, is a chelating agent. This means it attaches to iron and aluminum particles in the blood to form a complex. The complex is then excreted from the body."

Answered by AI